 | • レポートコード：GIR-2104Z04698 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、薬剤溶出性ステント（DES）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。薬剤溶出性ステント（DES）の種類別市場規模（コバルトクロム合金ステント、マグネシウム合金ステント、チロシンポリカーボネートステント、ニチノールステント、プラチナクロム合金ステント、ステンレス鋼ステント、その他の材料）、用途別市場規模（冠状動脈性心臓病、臨床）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・薬剤溶出性ステント（DES）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Vascular、Advantec Vascular、B.Braun Melsengen AG、Biosensors、Biotronik、Blue Medical、Boston Scientific、DISA Vascular、Essen、Medtronic Vascular、MicroPort Medical、MIV Therapeutics、Orbusneich、Promed Medical、Relisys Medical、Reva Medical、Sahajanand、Sino Medical、Sorin、Terumo Medical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：コバルトクロム合金ステント、マグネシウム合金ステント、チロシンポリカーボネートステント、ニチノールステント、プラチナクロム合金ステント、ステンレス鋼ステント、その他の材料 ・用途別分析2016年-2026年：冠状動脈性心臓病、臨床 ・薬剤溶出性ステント（DES）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・薬剤溶出性ステント（DES）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・薬剤溶出性ステント（DES）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・薬剤溶出性ステント（DES）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・薬剤溶出性ステント（DES）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Drug Eluting Stents (DES) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Drug Eluting Stents (DES) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Drug Eluting Stents (DES) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Drug Eluting Stents (DES) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cobalt-chromium alloy Stents
Magnesium alloy Stents
Tyrosine polycarbonate Stents
Nitinol Stents
Platinum chromium alloy Stents
Stainless steel Stents
Other Materials
Market segment by Application can be divided into
Coronary Heart Disease
Clinical
The key market players for global Drug Eluting Stents (DES) market are listed below:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Drug Eluting Stents (DES) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug Eluting Stents (DES) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Cobalt-chromium alloy Stents
1.2.3 Magnesium alloy Stents
1.2.4 Tyrosine polycarbonate Stents
1.2.5 Nitinol Stents
1.2.6 Platinum chromium alloy Stents
1.2.7 Stainless steel Stents
1.2.8 Other Materials
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug Eluting Stents (DES) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Global Drug Eluting Stents (DES) Market Size & Forecast
1.4.1 Global Drug Eluting Stents (DES) Sales in Value (2016-2026))
1.4.2 Global Drug Eluting Stents (DES) Sales in Volume (2016-2026)
1.4.3 Global Drug Eluting Stents (DES) Price by Type (2016-2026) & (USD/Unit)
1.5 Global Drug Eluting Stents (DES) Production Capacity Analysis
1.5.1 Global Drug Eluting Stents (DES) Total Production Capacity (2016-2026)
1.5.2 Global Drug Eluting Stents (DES) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug Eluting Stents (DES) Market Drivers
1.6.2 Drug Eluting Stents (DES) Market Restraints
1.6.3 Drug Eluting Stents (DES) Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Vascular
2.1.1 Abbott Vascular Details
2.1.2 Abbott Vascular Major Business
2.1.3 Abbott Vascular Drug Eluting Stents (DES) Product and Services
2.1.4 Abbott Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Advantec Vascular
2.2.1 Advantec Vascular Details
2.2.2 Advantec Vascular Major Business
2.2.3 Advantec Vascular Drug Eluting Stents (DES) Product and Services
2.2.4 Advantec Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 B.Braun Melsengen AG
2.3.1 B.Braun Melsengen AG Details
2.3.2 B.Braun Melsengen AG Major Business
2.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Product and Services
2.3.4 B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Biosensors
2.4.1 Biosensors Details
2.4.2 Biosensors Major Business
2.4.3 Biosensors Drug Eluting Stents (DES) Product and Services
2.4.4 Biosensors Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Biotronik
2.5.1 Biotronik Details
2.5.2 Biotronik Major Business
2.5.3 Biotronik Drug Eluting Stents (DES) Product and Services
2.5.4 Biotronik Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Blue Medical
2.6.1 Blue Medical Details
2.6.2 Blue Medical Major Business
2.6.3 Blue Medical Drug Eluting Stents (DES) Product and Services
2.6.4 Blue Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Boston Scientific
2.7.1 Boston Scientific Details
2.7.2 Boston Scientific Major Business
2.7.3 Boston Scientific Drug Eluting Stents (DES) Product and Services
2.7.4 Boston Scientific Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 DISA Vascular
2.8.1 DISA Vascular Details
2.8.2 DISA Vascular Major Business
2.8.3 DISA Vascular Drug Eluting Stents (DES) Product and Services
2.8.4 DISA Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Essen
2.9.1 Essen Details
2.9.2 Essen Major Business
2.9.3 Essen Drug Eluting Stents (DES) Product and Services
2.9.4 Essen Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Medtronic Vascular
2.10.1 Medtronic Vascular Details
2.10.2 Medtronic Vascular Major Business
2.10.3 Medtronic Vascular Drug Eluting Stents (DES) Product and Services
2.10.4 Medtronic Vascular Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 MicroPort Medical
2.11.1 MicroPort Medical Details
2.11.2 MicroPort Medical Major Business
2.11.3 MicroPort Medical Drug Eluting Stents (DES) Product and Services
2.11.4 MicroPort Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 MIV Therapeutics
2.12.1 MIV Therapeutics Details
2.12.2 MIV Therapeutics Major Business
2.12.3 MIV Therapeutics Drug Eluting Stents (DES) Product and Services
2.12.4 MIV Therapeutics Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Orbusneich
2.13.1 Orbusneich Details
2.13.2 Orbusneich Major Business
2.13.3 Orbusneich Drug Eluting Stents (DES) Product and Services
2.13.4 Orbusneich Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Promed Medical
2.14.1 Promed Medical Details
2.14.2 Promed Medical Major Business
2.14.3 Promed Medical Drug Eluting Stents (DES) Product and Services
2.14.4 Promed Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Relisys Medical
2.15.1 Relisys Medical Details
2.15.2 Relisys Medical Major Business
2.15.3 Relisys Medical Drug Eluting Stents (DES) Product and Services
2.15.4 Relisys Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Reva Medical
2.16.1 Reva Medical Details
2.16.2 Reva Medical Major Business
2.16.3 Reva Medical Drug Eluting Stents (DES) Product and Services
2.16.4 Reva Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Sahajanand
2.17.1 Sahajanand Details
2.17.2 Sahajanand Major Business
2.17.3 Sahajanand Drug Eluting Stents (DES) Product and Services
2.17.4 Sahajanand Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Sino Medical
2.18.1 Sino Medical Details
2.18.2 Sino Medical Major Business
2.18.3 Sino Medical Drug Eluting Stents (DES) Product and Services
2.18.4 Sino Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Sorin
2.19.1 Sorin Details
2.19.2 Sorin Major Business
2.19.3 Sorin Drug Eluting Stents (DES) Product and Services
2.19.4 Sorin Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Terumo Medical
2.20.1 Terumo Medical Details
2.20.2 Terumo Medical Major Business
2.20.3 Terumo Medical Drug Eluting Stents (DES) Product and Services
2.20.4 Terumo Medical Drug Eluting Stents (DES) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Drug Eluting Stents (DES) Sales by Manufacturer
3.1 Global Drug Eluting Stents (DES) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Drug Eluting Stents (DES) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Drug Eluting Stents (DES)
3.4 Market Concentration Rate
3.4.1 Top 3 Drug Eluting Stents (DES) Manufacturer Market Share
3.4.2 Top 6 Drug Eluting Stents (DES) Manufacturer Market Share
3.5 Global Drug Eluting Stents (DES) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Drug Eluting Stents (DES) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drug Eluting Stents (DES) Market Size by Region
4.1.1 Global Drug Eluting Stents (DES) Sales in Volume by Region (2016-2026)
4.1.2 Global Drug Eluting Stents (DES) Revenue by Region (2016-2026)
4.2 North America Drug Eluting Stents (DES) Revenue (2016-2026)
4.3 Europe Drug Eluting Stents (DES) Revenue (2016-2026)
4.4 Asia-Pacific Drug Eluting Stents (DES) Revenue (2016-2026)
4.5 South America Drug Eluting Stents (DES) Revenue (2016-2026)
4.6 Middle East and Africa Drug Eluting Stents (DES) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Drug Eluting Stents (DES) Sales in Volume by Type (2016-2026)
5.2 Global Drug Eluting Stents (DES) Revenue by Type (2016-2026)
5.3 Global Drug Eluting Stents (DES) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Drug Eluting Stents (DES) Sales in Volume by Application (2016-2026)
6.2 Global Drug Eluting Stents (DES) Revenue by Application (2016-2026)
6.3 Global Drug Eluting Stents (DES) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Drug Eluting Stents (DES) Sales by Type (2016-2026)
7.2 North America Drug Eluting Stents (DES) Sales by Application (2016-2026)
7.3 North America Drug Eluting Stents (DES) Market Size by Country
7.3.1 North America Drug Eluting Stents (DES) Sales in Volume by Country (2016-2026)
7.3.2 North America Drug Eluting Stents (DES) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Drug Eluting Stents (DES) Sales by Type (2016-2026)
8.2 Europe Drug Eluting Stents (DES) Sales by Application (2016-2026)
8.3 Europe Drug Eluting Stents (DES) Market Size by Country
8.3.1 Europe Drug Eluting Stents (DES) Sales in Volume by Country (2016-2026)
8.3.2 Europe Drug Eluting Stents (DES) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Drug Eluting Stents (DES) Sales by Type (2016-2026)
9.2 Asia-Pacific Drug Eluting Stents (DES) Sales by Application (2016-2026)
9.3 Asia-Pacific Drug Eluting Stents (DES) Market Size by Region
9.3.1 Asia-Pacific Drug Eluting Stents (DES) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Drug Eluting Stents (DES) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Drug Eluting Stents (DES) Sales by Type (2016-2026)
10.2 South America Drug Eluting Stents (DES) Sales by Application (2016-2026)
10.3 South America Drug Eluting Stents (DES) Market Size by Country
10.3.1 South America Drug Eluting Stents (DES) Sales in Volume by Country (2016-2026)
10.3.2 South America Drug Eluting Stents (DES) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drug Eluting Stents (DES) Sales by Type (2016-2026)
11.2 Middle East & Africa Drug Eluting Stents (DES) Sales by Application (2016-2026)
11.3 Middle East & Africa Drug Eluting Stents (DES) Market Size by Country
11.3.1 Middle East & Africa Drug Eluting Stents (DES) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Drug Eluting Stents (DES) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Drug Eluting Stents (DES) Typical Distributors
12.3 Drug Eluting Stents (DES) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Drug Eluting Stents (DES) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Drug Eluting Stents (DES) Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Vascular Major Business
Table 5. Abbott Vascular Drug Eluting Stents (DES) Product and Services
Table 6. Abbott Vascular Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 8. Advantec Vascular Major Business
Table 9. Advantec Vascular Drug Eluting Stents (DES) Product and Services
Table 10. Advantec Vascular Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. B.Braun Melsengen AG Basic Information, Manufacturing Base and Competitors
Table 12. B.Braun Melsengen AG Major Business
Table 13. B.Braun Melsengen AG Drug Eluting Stents (DES) Product and Services
Table 14. B.Braun Melsengen AG Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biosensors Basic Information, Manufacturing Base and Competitors
Table 16. Biosensors Major Business
Table 17. Biosensors Drug Eluting Stents (DES) Product and Services
Table 18. Biosensors Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Biotronik Basic Information, Manufacturing Base and Competitors
Table 20. Biotronik Major Business
Table 21. Biotronik Drug Eluting Stents (DES) Product and Services
Table 22. Biotronik Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Blue Medical Basic Information, Manufacturing Base and Competitors
Table 24. Blue Medical Major Business
Table 25. Blue Medical Drug Eluting Stents (DES) Product and Services
Table 26. Blue Medical Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 28. Boston Scientific Major Business
Table 29. Boston Scientific Drug Eluting Stents (DES) Product and Services
Table 30. Boston Scientific Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. DISA Vascular Basic Information, Manufacturing Base and Competitors
Table 32. DISA Vascular Major Business
Table 33. DISA Vascular Drug Eluting Stents (DES) Product and Services
Table 34. DISA Vascular Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Essen Basic Information, Manufacturing Base and Competitors
Table 36. Essen Major Business
Table 37. Essen Drug Eluting Stents (DES) Product and Services
Table 38. Essen Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Medtronic Vascular Basic Information, Manufacturing Base and Competitors
Table 40. Medtronic Vascular Major Business
Table 41. Medtronic Vascular Drug Eluting Stents (DES) Product and Services
Table 42. Medtronic Vascular Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 44. MicroPort Medical Major Business
Table 45. MicroPort Medical Drug Eluting Stents (DES) Product and Services
Table 46. MicroPort Medical Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. MIV Therapeutics Major Business
Table 49. MIV Therapeutics Drug Eluting Stents (DES) Product and Services
Table 50. MIV Therapeutics Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 52. Orbusneich Major Business
Table 53. Orbusneich Drug Eluting Stents (DES) Product and Services
Table 54. Orbusneich Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 56. Promed Medical Major Business
Table 57. Promed Medical Drug Eluting Stents (DES) Product and Services
Table 58. Promed Medical Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 60. Relisys Medical Major Business
Table 61. Relisys Medical Drug Eluting Stents (DES) Product and Services
Table 62. Relisys Medical Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 64. Reva Medical Major Business
Table 65. Reva Medical Drug Eluting Stents (DES) Product and Services
Table 66. Reva Medical Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 68. Sahajanand Major Business
Table 69. Sahajanand Drug Eluting Stents (DES) Product and Services
Table 70. Sahajanand Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 72. Sino Medical Major Business
Table 73. Sino Medical Drug Eluting Stents (DES) Product and Services
Table 74. Sino Medical Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Sorin Basic Information, Manufacturing Base and Competitors
Table 76. Sorin Major Business
Table 77. Sorin Drug Eluting Stents (DES) Product and Services
Table 78. Sorin Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 80. Terumo Medical Major Business
Table 81. Terumo Medical Drug Eluting Stents (DES) Product and Services
Table 82. Terumo Medical Drug Eluting Stents (DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Global Drug Eluting Stents (DES) Sales by Manufacturer (2019-2021e) & (K Units)
Table 84. Global Drug Eluting Stents (DES) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 85. Market Position of Manufacturers in Drug Eluting Stents (DES), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 86. Global Drug Eluting Stents (DES) Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Drug Eluting Stents (DES) Production Site of Key Manufacturer
Table 88. Global Drug Eluting Stents (DES) Sales by Region (2016-2021e) & (K Units)
Table 89. Global Drug Eluting Stents (DES) Sales by Region (2021-2026) & (K Units)
Table 90. Global Drug Eluting Stents (DES) Revenue by Region (2016-2021e) & (USD Million)
Table 91. Global Drug Eluting Stents (DES) Revenue by Region (2021-2026) & (USD Million)
Table 92. Global Drug Eluting Stents (DES) Sales by Type (2016-2021e) & (K Units)
Table 93. Global Drug Eluting Stents (DES) Sales by Type (2021-2026) & (K Units)
Table 94. Global Drug Eluting Stents (DES) Revenue by Type (2016-2021e) & (USD Million)
Table 95. Global Drug Eluting Stents (DES) Revenue by Type (2021-2026) & (USD Million)
Table 96. Global Drug Eluting Stents (DES) Price by Type (2016-2021e) & (USD/Unit)
Table 97. Global Drug Eluting Stents (DES) Price by Type (2021-2026) & (USD/Unit)
Table 98. Global Drug Eluting Stents (DES) Sales by Application (2016-2021e) & (K Units)
Table 99. Global Drug Eluting Stents (DES) Sales by Application (2021-2026) & (K Units)
Table 100. Global Drug Eluting Stents (DES) Revenue by Application (2016-2021e) & (USD Million)
Table 101. Global Drug Eluting Stents (DES) Revenue by Application (2021-2026) & (USD Million)
Table 102. Global Drug Eluting Stents (DES) Price by Application (2016-2021e) & (USD/Unit)
Table 103. Global Drug Eluting Stents (DES) Price by Application (2021-2026) & (USD/Unit)
Table 104. North America Drug Eluting Stents (DES) Sales by Country (2016-2021e) & (K Units)
Table 105. North America Drug Eluting Stents (DES) Sales by Country (2021-2026) & (K Units)
Table 106. North America Drug Eluting Stents (DES) Revenue by Country (2016-2021e) & (USD Million)
Table 107. North America Drug Eluting Stents (DES) Revenue by Country (2021-2026) & (USD Million)
Table 108. North America Drug Eluting Stents (DES) Sales by Type (2016-2021e) & (K Units)
Table 109. North America Drug Eluting Stents (DES) Sales by Type (2021-2026) & (K Units)
Table 110. North America Drug Eluting Stents (DES) Sales by Application (2016-2021e) & (K Units)
Table 111. North America Drug Eluting Stents (DES) Sales by Application (2021-2026) & (K Units)
Table 112. Europe Drug Eluting Stents (DES) Sales by Country (2016-2021e) & (K Units)
Table 113. Europe Drug Eluting Stents (DES) Sales by Country (2021-2026) & (K Units)
Table 114. Europe Drug Eluting Stents (DES) Revenue by Country (2016-2021e) & (USD Million)
Table 115. Europe Drug Eluting Stents (DES) Revenue by Country (2021-2026) & (USD Million)
Table 116. Europe Drug Eluting Stents (DES) Sales by Type (2016-2021e) & (K Units)
Table 117. Europe Drug Eluting Stents (DES) Sales by Type (2021-2026) & (K Units)
Table 118. Europe Drug Eluting Stents (DES) Sales by Application (2016-2021e) & (K Units)
Table 119. Europe Drug Eluting Stents (DES) Sales by Application (2021-2026) & (K Units)
Table 120. Asia-Pacific Drug Eluting Stents (DES) Sales by Region (2016-2021e) & (K Units)
Table 121. Asia-Pacific Drug Eluting Stents (DES) Sales by Region (2021-2026) & (K Units)
Table 122. Asia-Pacific Drug Eluting Stents (DES) Revenue by Region (2016-2021e) & (USD Million)
Table 123. Asia-Pacific Drug Eluting Stents (DES) Revenue by Region (2021-2026) & (USD Million)
Table 124. Asia-Pacific Drug Eluting Stents (DES) Sales by Type (2016-2021e) & (K Units)
Table 125. Asia-Pacific Drug Eluting Stents (DES) Sales by Type (2021-2026) & (K Units)
Table 126. Asia-Pacific Drug Eluting Stents (DES) Sales by Application (2016-2021e) & (K Units)
Table 127. Asia-Pacific Drug Eluting Stents (DES) Sales by Application (2021-2026) & (K Units)
Table 128. South America Drug Eluting Stents (DES) Sales by Country (2016-2021e) & (K Units)
Table 129. South America Drug Eluting Stents (DES) Sales by Country (2021-2026) & (K Units)
Table 130. South America Drug Eluting Stents (DES) Revenue by Country (2016-2021e) & (USD Million)
Table 131. South America Drug Eluting Stents (DES) Revenue by Country (2021-2026) & (USD Million)
Table 132. South America Drug Eluting Stents (DES) Sales by Type (2016-2021e) & (K Units)
Table 133. South America Drug Eluting Stents (DES) Sales by Type (2021-2026) & (K Units)
Table 134. South America Drug Eluting Stents (DES) Sales by Application (2016-2021e) & (K Units)
Table 135. South America Drug Eluting Stents (DES) Sales by Application (2021-2026) & (K Units)
Table 136. Middle East & Africa Drug Eluting Stents (DES) Sales by Country (2016-2021e) & (K Units)
Table 137. Middle East & Africa Drug Eluting Stents (DES) Sales by Country (2021-2026) & (K Units)
Table 138. Middle East & Africa Drug Eluting Stents (DES) Revenue by Country (2016-2021e) & (USD Million)
Table 139. Middle East & Africa Drug Eluting Stents (DES) Revenue by Country (2021-2026) & (USD Million)
Table 140. Middle East & Africa Drug Eluting Stents (DES) Sales by Type (2016-2021e) & (K Units)
Table 141. Middle East & Africa Drug Eluting Stents (DES) Sales by Type (2021-2026) & (K Units)
Table 142. Middle East & Africa Drug Eluting Stents (DES) Sales by Application (2016-2021e) & (K Units)
Table 143. Middle East & Africa Drug Eluting Stents (DES) Sales by Application (2021-2026) & (K Units)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Drug Eluting Stents (DES) Typical Distributors
Table 147. Drug Eluting Stents (DES) Typical Customers
List of Figures
Figure 1. Drug Eluting Stents (DES) Picture
Figure 2. Global Drug Eluting Stents (DES) Sales Market Share by Type in 2020
Figure 3. Cobalt-chromium alloy Stents
Figure 4. Magnesium alloy Stents
Figure 5. Tyrosine polycarbonate Stents
Figure 6. Nitinol Stents
Figure 7. Platinum chromium alloy Stents
Figure 8. Stainless steel Stents
Figure 9. Other Materials
Figure 10. Global Drug Eluting Stents (DES) Sales Market Share by Application in 2020
Figure 11. Coronary Heart Disease
Figure 12. Clinical
Figure 13. Global Drug Eluting Stents (DES) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Drug Eluting Stents (DES) Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Drug Eluting Stents (DES) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Drug Eluting Stents (DES) Sales (2016-2026) & (K Units)
Figure 35. Global Drug Eluting Stents (DES) Production Capacity (2016-2026) & (K Units)
Figure 36. Global Drug Eluting Stents (DES) Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Drug Eluting Stents (DES) Market Drivers
Figure 38. Drug Eluting Stents (DES) Market Restraints
Figure 39. Drug Eluting Stents (DES) Market Trends
Figure 40. Global Drug Eluting Stents (DES) Sales Market Share by Manufacturer in 2020
Figure 41. Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturer in 2020
Figure 42. Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Drug Eluting Stents (DES) Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Drug Eluting Stents (DES) Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Drug Eluting Stents (DES) Sales Market Share by Region (2016-2026)
Figure 46. Global Drug Eluting Stents (DES) Revenue Market Share by Region (2016-2026)
Figure 47. North America Drug Eluting Stents (DES) Revenue (2016-2026) & (USD Million)
Figure 48. Europe Drug Eluting Stents (DES) Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Drug Eluting Stents (DES) Revenue (2016-2026) & (USD Million)
Figure 50. South America Drug Eluting Stents (DES) Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Drug Eluting Stents (DES) Revenue (2016-2026) & (USD Million)
Figure 52. Global Drug Eluting Stents (DES) Sales Market Share by Type (2016-2026)
Figure 53. Global Drug Eluting Stents (DES) Revenue Market Share by Type (2016-2026)
Figure 54. Global Drug Eluting Stents (DES) Price by Type (2016-2026) & (USD/Unit)
Figure 55. Global Drug Eluting Stents (DES) Sales Market Share by Application (2016-2026)
Figure 56. Global Drug Eluting Stents (DES) Revenue Market Share by Application (2016-2026)
Figure 57. Global Drug Eluting Stents (DES) Price by Application (2016-2026) & (USD/Unit)
Figure 58. North America Drug Eluting Stents (DES) Sales Market Share by Country (2016-2026)
Figure 59. North America Drug Eluting Stents (DES) Revenue Market Share by Country (2016-2026)
Figure 60. North America Drug Eluting Stents (DES) Sales Market Share by Type (2016-2026)
Figure 61. North America Drug Eluting Stents (DES) Sales Market Share by Application (2016-2026)
Figure 62. Europe Drug Eluting Stents (DES) Sales Market Share by Country (2016-2026)
Figure 63. Europe Drug Eluting Stents (DES) Revenue Market Share by Country (2016-2026)
Figure 64. Europe Drug Eluting Stents (DES) Sales Market Share by Type (2016-2026)
Figure 65. Europe Drug Eluting Stents (DES) Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Drug Eluting Stents (DES) Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Drug Eluting Stents (DES) Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Drug Eluting Stents (DES) Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Drug Eluting Stents (DES) Sales Market Share by Application (2016-2026)
Figure 70. South America Drug Eluting Stents (DES) Sales Market Share by Country (2016-2026)
Figure 71. South America Drug Eluting Stents (DES) Revenue Market Share by Country (2016-2026)
Figure 72. South America Drug Eluting Stents (DES) Sales Market Share by Type (2016-2026)
Figure 73. South America Drug Eluting Stents (DES) Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Drug Eluting Stents (DES) Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Drug Eluting Stents (DES) Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Drug Eluting Stents (DES) Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Drug Eluting Stents (DES) Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の薬剤溶出性生体吸収性ステント市場 2021：企業別、地域別、種類・用途別 The Drug-Eluting Bioabsorbable Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 世界の抗再狭窄ステント市場 2021：企業別、地域別、種類・用途別 The Anti-Restenosis Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界のバルーン拡張型・自己拡張型ステント市場 2021：企業別、地域別、種類・用途別 The Balloon Expanding and Self-Expanding Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 世界の胃腸（GI）ステント市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gastrointestinal (GI) Stents Market The global Gastrointestinal (GI) Stents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界の食道ステント市場 2021：企業別、地域別、種類・用途別 The Esophageal Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …